1.Neoadjuvant treatment for locally advanced esophageal cancer
Journal of International Oncology 2008;35(8):599-602
Neoadjuvant therapy refers to preoperative adjuvant treatment based on the experiences of successful postoperative adjuvant treatment. The neoadjuvant therapy, which aims at increasing the possibility of cancer resection and improving patients survival, includes neoadjuvant chemotherapy, neoadjuvanl radiother-apy and neoadjuvant chemoradiation. Neoadjuvant chemoradiation may be the preferred neoadjuvant modality to increase resection rate and improve survival rate in patients with locally advanced esophageal cancer.
2.Mode of Long-chain Alkane Uptake by a Pseudomonas aeruginosa
Ye LIU ; Tao FU ; Bo-Zhong MU ;
Microbiology 1992;0(03):-
The mode of long-chain alkane uptake by Pseudomonas aeruginosa (CGMCC 1.1785) was studied. P. aeruginosa 1.1785 is capable of using solid long-chain alkane as sole carbon source and producing surface active compound as metabolite. The mass transfer limitation in uptake of alkane was confirmed from the observation that interfacial area of eicosane with water dominates the growth rate of this strain. The enhancement of eicosane uptake by rhamnolipid was mainly caused by increase of interfacial area, since the pseudosolubilized alkane can not support the growth of P. aeruginosa 1.1785. Cell surface hydrophobicity was increased dramatically at the initial phase of growth and followed by a gradual decrease, which indicates that different modes are employed by P. aeruginosa 1.1785 at different growth phase. Therefore, the surfactant mediated mode can be negligible in the uptake process, while the directly attachment mode may not work throughout the growth of P. aeruginosa 1.1785. We proposed a novel uptake mode, in which the chemotaxis of this strain plays an important role.
3.Isolation and Identification of a Lipopeptide
Ying-Nian LV ; Shi-Zhong YANG ; Bo-Zhong MU ;
Microbiology 1992;0(01):-
A lipopeptide compound was isolated from the culture of Bacillus subtilis HSO121 by methods of acidic precipitation, solvent extract, fractional precipitation, adsorption and prepared thin-layer chromatography; and its molecular structure was determined by by ninhydrin assay and IR methods following the Amino analysis, MS-MS and ESI-MS. It shows that the isolated lipopeptide consists of two homologues with molecular mass 1,022D and 1,036D and bearing a cyclic structure with the amino acid sequence Leu-Leu-Asp-Val-Leu-Leu-Glu in the peptide chain, which indicates that the isolated lipopeptide falls into the analogs of surfactin.
4.Advance in Mechanism of Alkane Uptake by Microorganism
Ye LIU ; Bo-Zhong MU ; Hong-Lai LIU ;
Microbiology 1992;0(02):-
Recent advance in researches of alkane uptake by microorganisms was reviewed. To improve efficiency of bioremediation, knowledge of mechanism of water-insoluble substrate, especially alkanes, uptake by microorganism is badly needed. Powered by novel ideas and advanced techniques, more findings and conclusions were reported. Effects of surfactants on uptake of alkane, adjustment on cell surface properties and transport of alkane into the cells were discussed in this review, at the same time, evidences from analyses of cell ultra-structure and researches on cell chemotaxis were cited. There are still some questions in this area should be taken into consideration.
5.A Strategy for Bioproduction of Rare Sugars: Izumoring
Wan-Meng MU ; Tao ZHANG ; Bo JIANG ; Hua ZHANG ;
China Biotechnology 2006;0(07):-
Rare sugars were defined as monosaccharides and their derivatives that rarely exist in nature. They played an important role in food, health, medicine and etc A strategy for bioproduction of rare sugars, namely Izumoring, was described. By the Izumoring method, all monosaccharides and polyols could be linked, using enzymatic reaction with D-tagatose 3-epimerase, aldose isomerases and polyol dehydrogenases. Izumoring for hexoses, pentoses and tetroses were designed respectively. According to this strategy, the bioproduction routes of various rare sugars, using microbial and enzymatic reactions, could be obtained. In addition, the future research tendency of biotransformation of rare sugars was put forward.
6.Purification and Characterization of L-AI from Bacillus Stearothermophilis IAM 11001 Expressed in E.coli
Li-Fang CHENG ; Wan-Meng MU ; Tao ZHANG ; Bo JIANG ;
China Biotechnology 2006;0(09):-
Thermostable L-arabinose isomerase (L-AI) is the most potential enzyme for the biological production of D-tagatose from D-galactose, a novel functional factor. Gene araA encoding the L-arabinose isomerase from Bacillus stearothermophilis IAM 11001 was cloned and expressed in Escherichia coli. The araA gene of 1491 bp has 95% identity with L-AI from Thermus sp. IM6501. The GenBank accession number for the nucleotide sequence of this araA gene determined in this work is EU394214.The bacterium was induced by IPTG and analyzed by SDS-PAGE, approximately 59 kDa exogenous protein was observed on the SDS-PAGE. The recombinant L-AI was purified to electrophoretical homogeneity with affinity chromatography, and the activity of recombinant L-AI was also studied. The bioconversion rate of D-galactose to D-tagatose reached 39.4% after 24h whole cell reaction.
7.Identification of a Bacillus sp. Strain with Fibrinolytic Activity and Primary Study on Fermentation Process
Zhu LIU ; Ying HUA ; Bo JIANG ; Wan-Meng MU ;
Microbiology 2008;0(09):-
An extracellar fibrinolytic strain was isolated from fermented shrimp paste. In addition to general physiological and biochemical properties, the strain was identified by 16S rDNA sequence and systematic analysis. The results showed that 16S rDNA sequence of the strain had high similarity with AY601723 and AB195282, suggesting that the strain is a subspecies of Bacillus sp. It was named as Bacillus sp. nov. SK006 by CCTCC. The medium composition and fermentation conditions for fibrinolytic enzyme production were also optimized in the research.
8.Research Progress on the Microbial L-Arabinose Isomerase
Li-Fang CHENG ; Wan-Meng MU ; Tao ZHANG ; Bo JIANG ;
Microbiology 2008;0(10):-
L-arabinose isomerase (L-AI) can isomerize L-arabinose and D-galactose into L-ribulose and D-tagatose, respectively, which is currently the most effective biological catalyst for D-tagatose production. The crystal structure of L-AI has been solved recently and its gene has been cloned, sequenced and overex- pressed. L-AI improved by protein engineering will be the dominant enzyme for industrial production of D-tagatose. This paper reviewed researches on protein structure and function, properties and application in D-tagatose production of L-AI, and the long-term potential development of L-AI was prospected.
9.Meta-analysis of medium-and long-term efficacy of loading statins after coronary artery bypass grafting surgery
Bin CHENG ; Junsheng MU ; Jianqun ZHANG ; Ping BO
Chinese Journal of Thoracic and Cardiovascular Surgery 2015;31(11):679-682,701
Objective To evaluate the medium-and long-term efficacy of loading statins after coronary artery bypass grafting surgery by comparing patients undergoing coronary artery bypass grafting surgery(CABG) using a loading dose statins or a regular dose of statins.Methods Cochrane Library, WanFang database etc database web were searched for the efficacy of a loading dose of statins after CABG in randomized controlled trials(RCTs).The quality of included studies was evaluated according to the Newcastle-Ottawa Scale(NOS).The statistical results of treatment were represented by weighted mean difference (WMD) , the odds ratio(OR) and 95% confidence intervals(CI).Revman 5.2 software was used for data processing and analysis.Results There are eight studies including 8 676 cases, 4 352 cases are in group using a loading dose of statins, 4 324 cases are in group using a regular dose of statins.Meta-analysis showed the level of low-density lipoprotein(LDL-C) in patients who took a loading dose of statins after CABG(WMD =-42.15,95% CI:-44.45~-39.84, P <0.00001);the number of death caused by myocardial infarction (OR =0.74, 95 % CI: 0.60~ 0.91, P =0.005);the number of patients occurred myocardial infarction (OR =0.78, 95 % CI: 0.66~ 0.92, P =0.004);the number of patients undergoing secondary CABG (OR =0.72, 95% CI: 0.63~ 0.82, P < 0.00001);the number of patients occurred drug side effects(OR =1.43, 95% CI: 1.06~ 1.93, P =0.02);the number of patients occurred grafts restenosis by intravascular ultrasound(IVUS) (OR =0.59, 95% CI: 0.50~0.70, P <0.0001).The data above reached statistically significant difference.Conclusion Comparing patients who used a loading dose of statins and those who used a regular dose of statins after CABG.The medium-and long-term efficacy of a loading dose of statins showed significantly reduction of LDL-C;reduction of the occurrence to cardiac events, such as death caused by myocardial infarction, myocardial infarction and secondary CABG;reduction of grafts restenosis.The incidence of drug side effects was a little higher in a loading dose of statin group.But the majority of patients did not show serious drug side effects after using a loading dose of statins.In summary, the medium-and long-term efficacy of a loading dose of statins after CABG is better than that of a regular dose of statins.
10.Prostaglandin E_2 in peripheral blood and tumor mass of patients with gastric cancer
Huihong YU ; Xiaoling WU ; Mu ZHANG ; Bo NING
Journal of Third Military Medical University 1988;0(05):-
Objective To assess the prostaglandin E2 (PGE2) levels in tumor mass and peripheral blood of patients with gastric cancer and explore their clinical significance. Methods The PGE2 levels in tumor mass, tumor margins of excision and peripheral blood of 40 patients with gastric cancer were measured by a kit of PGE2 ELISA. Results The PGE2 levels were higher in the tissues of gastric cancer than in tumor margins of excision [(8.225?2.425) vs (1.669?0.287) ng/g, P